Top Markets
#1 Pleasing Gold Pleasing Gold +1,501.12%
#2 PulseChain PulseChain +54.75%
#3 Ontology Gas Ontology Gas +36.56%
#4 Merlin's Seal BTC Merlin's Seal BTC +33.29%
#5 BOOK OF MEME BOOK OF MEME +30.64%
#6 ConstitutionDAO ConstitutionDAO +26.74%
#7 Unit Pump Unit Pump +26.20%
#8 Pump.fun Pump.fun +24.87%
#9 Neiro Neiro +24.52%
#10 Collect on Fanable Collect on Fanable +24.26%
Coin of the day
Pleasing Gold Pleasing Gold
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Molecure S.A. Molecure S.A.

Molecure S.A.

MOC
Clasificación en acciones #26168
Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in... Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in the research, development, and commercialization of innovative therapies designed to combat neoplastic (cancer) and inflammatory conditions. The company's pipeline prominently features OATD-01, a chitotriosidase/acidic mammalian chitinase inhibitor that has successfully advanced through Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and sarcoidosis. Additionally, Molecure is progressing its YKL-40 program for cancer and fibrosis, OATD-02 for oncology applications, and a Deubiquitinase program. Established in 2012, this Warsaw-headquartered enterprise adopted the name Molecure S.A. in March 2022, having previously been known as OncoArendi Therapeutics S.A.
Precio por acción
$1.73
Capitalización bursátil
$42.88M
Cambio (1 día)
2.16%
Cambio (1 año)
-18.85%
País
PL
Comercio Molecure S.A. (MOC)

Categoría

Healthcare
Ingresos de Molecure S.A. (MOC)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de Molecure S.A., los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Molecure S.A. desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US